Methyl-ddPCR NIPT
Financiado
Proof of Concept study for the development of methylation based NIPT for trisomy...
Proof of Concept study for the development of methylation based NIPT for trisomy 21 using droplet digital PCR
Scientific and medical evidence indicate that non-invasive prenatal testing (NIPT) offers to pregnant women a safe option
during their pregnancy as it provides no risk of miscarriage. The NIPT is based on a genetic examination of...
Scientific and medical evidence indicate that non-invasive prenatal testing (NIPT) offers to pregnant women a safe option
during their pregnancy as it provides no risk of miscarriage. The NIPT is based on a genetic examination of plasma collected
from a pregnant woman. The discovery of cell-free fetal DNA (cff DNA) in maternal plasma during pregnancy provides a
promising source of fetal genetic material for the development of reliable methods for NIPT. In the last years, NIPT has been
widely adopted in the clinical setting as its accuracy has been dramatically improved mainly due to the introduction of new
generation sequencing (NGS) employing whole genome or targeted approaches. However, NGS based assays consist of
high complexity steps and high cost. This raises concerns about inequity in NIPT access, especially for women from low
socioeconomic groups and developed countries who cannot afford NIPT test.
The proposed study stems out from a frontier research performed during two previously funded ERC Grants. Our goal is to
take the first steps towards adapting and translating our previous findings into a safe, fast, accurate and affordable
methylation based non-invasive prenatal test for the detection of Down syndrome using a high precision technology such as
droplet digital PCR (ddPCR).
ver más
Duración del proyecto: 18 meses
Fecha Inicio: 2020-12-08
Fecha Fin: 2022-06-30
Fecha Fin: 2022-06-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-06-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
ERC-2020-POC:
Call for proposals for ERC Proof of Concept Grant
Cerrada
hace 4 años
Presupuesto
El presupuesto total del proyecto asciende a
150K€
Líder del proyecto
NIPD GENETICS PUBLIC COMPANY LIMITED
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
1.16M€ |
Participante